CIK 0001384101 · Large accelerated filer
VERACYTE, INC.
Sign in to watch- Ticker
- VCYT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205455398
- Phone
- (650) 243-6300
- Business address
- 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CALDEROME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,858,989
- in 9 filings, $2.9M under 10b5-1 plans
Net −$2,858,989. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | McGuire Annie EVP, General Counsel | Shares withheld for taxes 10b5-1 | −3,215 | $44.88 | $144K | 134,414 |
| 2026-09-02 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes 10b5-1 | −3,603 | $44.88 | $162K | 169,677 |
| 2026-09-02 | Febbo Phillip G. Chief Scientific & Med Officer | Shares withheld for taxes 10b5-1 | −3,639 | $44.88 | $163K | 146,158 |
| 2026-09-02 | Wygant Jonathan VP, Chief Accounting Officer | Shares withheld for taxes | −1,361 | $44.88 | $61K | 43,226 |
| 2026-09-02 | Stapley Marc Chief Executive Officer | Shares withheld for taxes | −8,782 | $44.88 | $394K | 432,073 |
| 2026-09-01 | Bhanji Muna Director | Sale 10b5-1 | −1,864 | $42.97 | $80K | 42,718 |
| 2026-06-18 | EASTHAM KARIN Director | Sale 10b5-1 | −3,200 | $52.78 | $169K | 15,626 |
| 2026-06-18 | EASTHAM KARIN Director | Sale 10b5-1 | −529 | $53.55 | $28K | 15,097 |
| 2026-06-11 | Miller Thomas F. Director | Grant or award | +5,272 | 31,100 | ||
| 2026-06-11 | Barr Eliav Director | Grant or award | +5,272 | 56,461 | ||
| 2026-06-11 | Bhanji Muna Director | Grant or award | +5,272 | 44,582 | ||
| 2026-06-11 | Holstein Jens Director | Grant or award | +5,272 | 32,471 | ||
| 2026-06-11 | Shafer David Brent Director | Grant or award | +5,272 | 31,100 | ||
| 2026-06-11 | EPSTEIN ROBERT S Director | Grant or award | +5,272 | 57,718 | ||
| 2026-06-11 | EASTHAM KARIN Director | Grant or award | +5,272 | 18,826 | ||
| 2026-06-11 | JONES EVAN/ FA Director | Grant or award | +5,272 | 34,634 | ||
| 2026-06-04 | Leite John Global Chief Commercial Off | Sale 10b5-1 | −13,975 | $50.07 | $700K | 132,305 |
| 2026-06-04 | McGuire Annie EVP, General Counsel | Sale 10b5-1 | −1,400 | $49.31 | $69K | 139,016 |
| 2026-06-04 | McGuire Annie EVP, General Counsel | Sale 10b5-1 | −1,776 | $50.12 | $89K | 137,240 |
| 2026-06-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −1,600 | $49.28 | $79K | 175,241 |
Page 2 of 9 · 168 trades